Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(0.10) per share.
Synlogic Announces 1-For-15 Reverse Stock Split
Synlogic, Inc. (NASDAQ:SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, today announced that it will implement a
